Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 16,392 shares at $86.52 ($1.4M) on 2019-02-15, disclosed to the SEC on 2019-02-19.
Open-market sale of $1.4M HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.52 | 8,196 | $709K | 50.0% |
| 2 | $86.52 | 8,196 | $709K | 50.0% |
| Total | $86.52 avg | 16,392 | $1.4M | 100% |
| Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |
| HAE | SELL | 2017-04-27 | $343K | — | Filing → |